Bristol Myers' legacy drug sales plunged 20% amid generic erosion and Medicare changes, spotlighting its shift to a newer growth portfolio.
Vous n'êtes pas connecté
With the ease in inflationary pressure, the Zacks Medical - Generic Drugs industry is expected to benefit from declining costs. New product launches provide some respite to AMPH, RDY, and TEVA.
Bristol Myers' legacy drug sales plunged 20% amid generic erosion and Medicare changes, spotlighting its shift to a newer growth portfolio.
Rising premiums, ongoing technological innovation and the growing demand for Medicare plans are anticipated to propel the performance of the Zacks...
Rising premiums, ongoing technological innovation and the growing demand for Medicare plans are anticipated to propel the performance of the Zacks...
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
The new initiative of the Dangote Petroleum Refinery has continued to draw accolades from energy experts in the country, with some describing it as...
The Zacks Internet - Delivery Services industry participants like GDDY, VIPS, QNST and ASUR are poised to benefit from increasing smartphone and...
Momentum in cloud computing, IoT, auto, and AI is likely to favor the prospects of Zacks Computer - Storage Devices industry players like WDC, NTAP,...
Robust online betting demand bodes well for the Gaming industry. Stocks like MLCO, ACEL and BALY benefit from improving industry trends.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.